Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:23 AM UTC
| NCT Number | NCT05462106 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | PHASE1 |
| Target Enrollment | 304 participants |
| Active Locations | 13 sites in the US |
| Sponsor | AC Immune SA |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT05462106 is currently recruiting participants. This phase1 study for alzheimer's disease is actively seeking new participants at 13 locations across the United States. The study is sponsored by AC Immune SA. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05462106 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05462106 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.